Skip to main content

ETF Objective

The Fund seeks to provide investment results that correspond to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index. The Underlying Index is designed to provide exposure to exchange-listed companies that are directly involved in Chinas biotechnology industry.

Stock Chart

as of 3:27 PM ET 05/12/2022

Performance

  • 1 Week
  • n/a
  • 1 Month
  • n/a
  • 3 Months
  • n/a
  • 1 Yr Return
  • n/a
  • 5 Yr Return
  • n/a

Sector Breakdown

Health Care 90.02%
Non Classified Equity 4.06%
Consumer Goods 3.37%
Basic Materials 2.54%

Geographic Exposure

China 94.74%
Hong Kong 5.25%
United States 0.06%
Unidentified 0.00%

Top 10 Holdings

Symbol Company Name % Of Assets
BGNE Beigene Ltd DR 5.68%

ETF Overview

Sponsor Global X
iNav Ticker F3T9
Inception Date 09/22/2020
Name Glbl X China Btech Innov
CUSIP 37954Y251
Prospectus Date 04/01/2022

ETF Characteristics

Market Capitalization 11.12 B
Total Net Assets 2.70
Management Fee 0.65%
Administration Fee 0.00%
Asset Class Equity
Sub Asset Class China Region Funds
Number Of Holdings 38
Expense Ratio 0.65
Dividend n/a
Dividend Frequency Annually

Recommended for You